-
81
-
82
A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma
Published 2025-01-01“…Xing Wei,1 Ziwei Guo,2 Tingting Zhang,3 Jun Liang1 1Department of Medical Oncology, Peking University International Hospital, Beijing, People’s Republic of China; 2Department of Medicine, Double Crane Runchuang Technology (Beijing) Co., Ltd, Beijing, People’s Republic of China; 3Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing, People’s Republic of ChinaCorrespondence: Jun Liang, Email Junl1959@163.comBackground: The prognosis is extremely troubling in advanced hepatocellular carcinoma (HCC). …”
Get full text
Article -
83
The Utilization of Ultrasound-Guided Regional Nerve Blocks in Anesthetic Management for Fracture Surgery
Published 2025-01-01“…Ruofan Yi,1 Zeng Li,1 Xingjun Yang,2 Ting Huang,1 Hongjun Liu,1 Jun Zhang2 1Department of Anesthesiology, The 955th Hospital of Chinese People’s Liberation Army, Tibet, 854000, People’s Republic of China; 2Department of General Surgery, The 955th Hospital of Chinese People’s Liberation Army, Tibet, 854000, People’s Republic of ChinaCorrespondence: Jun Zhang, Department of General Surgery, The 955th Hospital of Chinese People’s Liberation Army, No. 52, Gadong Street, Karuo District, Chamdo, Tibet, 854000, People’s Republic of China, Tel +86 0895 4820722, Email junzhangyz@outlook.com Hongjun Liu Department of Anesthesiology, The 955th Hospital of Chinese People’s Liberation Army, No. 52, Gadong Street, Karuo District, Chamdo, Tibet, 854000, People’s Republic of China, Tel +86 0895-4820775, Email hongjunliumzk@outlook.comAbstract: Fracture surgeries are frequently accompanied by severe pain, necessitating efficacious pain management strategies to enhance postoperative recovery. …”
Get full text
Article -
84
-
85
The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
Published 2025-01-01“…Zi-Chen Yu,1,2 Zheng-Kang Fang,1,2 Yang Yu,3 Si-Yu Liu,4 Kai-Di Wang,1,5 Zhe-Jin Shi,1,5 Li-Ming Jin,1 Xiao-Kun Huang,1,2 Yi Lu,1 Guo-Liang Shen,1 Jun-Wei Liu,1 Dong-Sheng Huang,1 Cheng-Wu Zhang,1 Lei Liang1 1Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, General Surgery, Cancer Center, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 3Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China; 4Department of Laboratory Medicine, The Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Zhejiang University Lishui Hospital, Lishui, Zhejiang, People’s Republic of China; 5Department of the second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Lei Liang, General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, People’s Republic of China, Email liangl1992@hotmail.comBackground & Aims: Dual-phenotype hepatocellular carcinoma (DPHCC) is discernible from classical HCC (CHCC) in its morphology and is characterized by the co-expression of both CHCC and cholangiocyte markers. …”
Get full text
Article -
86